EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

No winners or losers: clinical chemistry-based biological aging metrics perform similarly across cohorts and health outcomes

Guillaume Provost, Kamaryn Tanner, Véronique Legault, Luigi Ferrucci iD, Stefania Bandinelli, Linda P Fried, Daniel W Belsky iD, Benoit Laurent iD, Alan A Cohen iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 05.10.2025 · 80 (11)

DOI: 10.1093/gerona/glaf179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 12.08.2025. Verfasst von Guillaume Provost und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Hauptthemen laut MEDLINE: Aging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is the leading risk factor for most chronic disease. However, disease risk varies substantially between individuals of the same age. Biological aging measures attempt to quantify this difference using biomarkers; such measures have amassed substantial evidence as reliable correlates of morbidity and mortality. Although many have been developed throughout the years, there is no clear consensus as to which one is the best, if any. This study evaluates four methods for measuring biological aging: Klemera and Doubal’s method for biological age (KDM BA), phenotypic age (PA), homeostatic dysregulation (DM), and Pace of Aging (Pace). Using five cohort studies from four different countries (InCHIANTI from Italy, WHAS I and II from the United States, NuAge from Canada, and the UK Biobank), we assessed the relationship of these metrics with six health outcomes. The metrics were calculated using a consistent set of biomarkers to facilitate comparison. The biological aging measures correlated only weakly with each other (r > .5 for six of 21 correlations). The meta-analyses performed on the results from each dataset revealed that all biological age measures were significantly associated with at least one health outcome; however, no single metric consistently outperformed the others, with strength of association strikingly similar across metrics. This study is the first to combine an international multicohort analysis using a consistent set of biomarkers across biological age metrics. While there are no net winners or losers, effect sizes are heterogeneous across cohorts, highlighting the importance of replicating findings in different contexts and with different metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingHumansAgedBiomarkersMaleFemaleCohort StudiesMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Biological ageBiomarkersHealthy aging

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, NY, United States.
  • Nursing School, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Intramural Research Program of the National Institute on Aging, Baltimore, MD, United States.
  • Geriatric Unit, Azienda Sanitaria Firenze, Florence, Tuscany, Italy.
  • Columbia University Mailman School of Public Health, New York, NY, United States.

ORCID-Profile: Luigi Ferrucci, Daniel W Belsky, Benoit Laurent, Alan A Cohen

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Provost, G., Tanner, K., Legault, V., Ferrucci, L., Bandinelli, S., Fried, L. P., Belsky, D. W., Laurent, B., & Cohen, A. A. (2025). No winners or losers: clinical chemistry-based biological aging metrics perform similarly across cohorts and health outcomes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(11). https://doi.org/10.1093/gerona/glaf179

Vancouver

Provost G, Tanner K, Legault V, Ferrucci L, Bandinelli S, Fried LP, et al. No winners or losers: clinical chemistry-based biological aging metrics perform similarly across cohorts and health outcomes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025;80(11). doi:10.1093/gerona/glaf179

BibTeX
@article{Provost2025,
  author = {Provost, Guillaume and Tanner, Kamaryn and Legault, Véronique and Ferrucci, Luigi and Bandinelli, Stefania and Fried, Linda P and Belsky, Daniel W and Laurent, Benoit and Cohen, Alan A},
  title = {No winners or losers: clinical chemistry-based biological aging metrics perform similarly across cohorts and health outcomes},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  volume = {80},
  number = {11},
  doi = {10.1093/gerona/glaf179}
}
Kostenlos starten →